Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1649 1675
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17914121 | COMPOSITIONS AND METHODS FOR TREATING A NEURODEGENERATIVE OR DEVELOPMENTAL DISORDER | Non-Final OA | The Regents of the University of California |
| 17744614 | ANTIGENIC NEURON SPECIFIC ENOLASE PEPTIDES FOR DIAGNOSING AND TREATING AUTISM | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18657340 | CITRULLINATED BRAIN AND NEUROLOGICAL PROTEINS AS BIOMARKERS OF BRAIN INJURY OR NEURODEGENERATION | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18028932 | PEPTIDE FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17980435 | BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS | Non-Final OA | Board of Regents, The University of Texas System |
| 18147360 | METHODS OF DIAGNOSING BRAIN INJURY | Non-Final OA | Abbott Laboratories |
| 17747397 | METHODS OF EVALUATING BRAIN INJURY IN A PEDIATRIC SUBJECT | Final Rejection | Abbott Laboratories |
| 18776405 | USE OF ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES FOR THE TREATMENT AND DIAGNOSIS OF MOOD DISORDERS | Non-Final OA | Neuracle Science Co., Ltd. |
| 18773152 | METHODS FOR EVALUATING AND IMPROVING COGNITIVE FUNCTION | Non-Final OA | THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH |
| 18770847 | THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATING, RELIEVING, OR ALLEVIATING ALZHEIMER'S DISEASE | Non-Final OA | BIOMED INDUSTRIES, INC. |
| 17769165 | MUSCLE REGENERATION AND GROWTH | Non-Final OA | Brown University |
| 16312346 | Blood Test for Screening Out Amyloid and Alzheimers Disease Presence | Non-Final OA | University of North Texas Health Science Center at Fort Worth |
| 18246193 | COMPOSITION FOR PREVENTING OR TREATING DEMENTIA, CONTAINING PEPTIDE NUCLEIC ACID COMPLEX AS ACTIVE INGREDIENT | Non-Final OA | SEASUN THERAPEUTICS |
| 17048059 | MODULATING IMMUNE RESPONSE VIA TARGETING OF OLFACTORY RECEPTOR ACTIVITY | Non-Final OA | La Jolla Institute for Allergy and Immunology |
| 17907624 | THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND ASSOCIATED BIOMARKERS BASED ON TRK-B | Non-Final OA | FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA |
| 17800096 | METHODS OF THERAPEUTIC PROGNOSTICATION | Non-Final OA | GENETIKAPLUS LTD. |
| 17826923 | METHOD FOR ASSISTING WITH DIAGNOSIS OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT, BIOMARKER, REAGENT KIT, AND DEVICE | Non-Final OA | FUJIFILM Wako Pure Chemical Corporation |
| 17119776 | CHANNEL MODULATORS | Non-Final OA | OCUNEXUS THERAPEUTICS, INC. |
| 17544007 | METHODS AND COMPOSITIONS FOR DIAGNOSING NEURODEGENERATIVE DISEASE | Final Rejection | Board of the Regents of the University of Nebraska |
| 17515269 | SYSTEM AND METHOD FOR TESTING EFFECTS OF CHEMICAL COMPOUNDS ON COGNITIVE FUNCTION | Non-Final OA | CCLabs Pty Ltd |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy